2021 annual financial data
NovaBridge Biosciences 2021 Operating margin
Direct answer
Operating margin was -2,353.06%.
Operating income was -2,071,307,000 CNY and net income was -2,331,541,000 CNY.
Operating cash flow was Not available.
Get free NovaBridge Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 88,026,000 CNY
- Operating income
- -2,071,307,000 CNY
- Net income
- -2,331,541,000 CNY
- Operating cash flow
- Not available